It is a clone of this request.
|Submitted||July 28, 2017|
To Whom It May Concern:
This is a request under the Freedom of Information Act.
I am seeking all FDA documents dealing with Oxiracetam [(RS)-2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide]. This should include Investigational New Drug Applications, compounding pharmacy requests, import alerts, import records and records of seizures, New Dietary Ingredient Notifications and resulting correspondence, plus internal and external documents not limited to email correspondences, white papers, and opinions.
Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.
There are no files associated with this request.